Cross-presentation by dendritic cells
暂无分享,去创建一个
O. Joffre | S. Amigorena | E. Segura | A. Savina | É. Segura
[1] V. Soumelis,et al. Characterization of resident and migratory dendritic cells in human lymph nodes , 2012, The Journal of experimental medicine.
[2] C. Figdor,et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. , 2012, Blood.
[3] R. Yates,et al. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH‐independent manner , 2012, The EMBO journal.
[4] W. Jefferies,et al. A CD74-DEPENDENT MHC CLASS I ENDOLYSOSOMAL CROSS-PRESENTATION PATHWAY , 2012, Nature Immunology.
[5] C. Figdor,et al. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. , 2011, Blood.
[6] J. Enninga,et al. Sec22b Regulates Phagosomal Maturation and Antigen Crosspresentation by Dendritic Cells , 2011, Cell.
[7] P. van Endert,et al. A proteasome‐dependent, TAP‐independent pathway for cross‐presentation of phagocytosed antigen , 2011, EMBO reports.
[8] J. Weissman,et al. Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum , 2011, Science.
[9] Even Fossum,et al. Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type , 2011, The Journal of Immunology.
[10] C. Figdor,et al. Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. , 2011, Blood.
[11] K. Murphy,et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells , 2011, The Journal of experimental medicine.
[12] R. Schreiber,et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors , 2011, The Journal of experimental medicine.
[13] Shusaku Mizukami,et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells , 2011, Proceedings of the National Academy of Sciences.
[14] J. Penninger,et al. Brief Definitive Report , 2003 .
[15] J. Berman,et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. , 2011, Immunity.
[16] Michelle M. Sandau,et al. CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. , 2011, Immunity.
[17] M. Albert,et al. Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy , 2011, Nature Medicine.
[18] Li Wu,et al. Human Dendritic Cell Subsets from Spleen and Blood Are Similar in Phenotype and Function but Modified by Donor Health Status , 2011, The Journal of Immunology.
[19] Sven Burgdorf,et al. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation , 2011, Proceedings of the National Academy of Sciences.
[20] M. Bevan,et al. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection , 2011, Nature.
[21] L. Bracci,et al. Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming , 2011, The Journal of Immunology.
[22] Li Wu,et al. The Acquisition of Antigen Cross-Presentation Function by Newly Formed Dendritic Cells , 2011, The Journal of Immunology.
[23] P. Murray. Faculty Opinions recommendation of CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. , 2011 .
[24] Andrea J. Radtke,et al. Dendritic Cells and Hepatocytes Use Distinct Pathways to Process Protective Antigen from Plasmodium in vivo , 2011, PLoS pathogens.
[25] Yasunobu Miyake,et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. , 2011, Immunity.
[26] R. Steinman,et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A , 2011, Proceedings of the National Academy of Sciences.
[27] M. Nussenzweig,et al. Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes , 2010, The Journal of Immunology.
[28] P. Kantoff,et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.
[29] M. Alexander-Miller,et al. Functional Divergence among CD103+ Dendritic Cell Subpopulations following Pulmonary Poxvirus Infection , 2010, Journal of Virology.
[30] P. van Endert,et al. Fusion Proteins for Versatile Antigen Targeting to Cell Surface Receptors Reveal Differential Capacity to Prime Immune Responses , 2010, The Journal of Immunology.
[31] P. Cresswell,et al. Defective Cross-Presentation of Viral Antigens in GILT-Free Mice , 2010, Science.
[32] C. Dutertre,et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.
[33] P. Rod Dunbar,et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens , 2010, The Journal of experimental medicine.
[34] Anna M. Keller,et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.
[35] R. Sauerwein,et al. Empowering malaria vaccination by drug administration. , 2010, Current opinion in immunology.
[36] Regina M. Krohn,et al. NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes , 2010, Proceedings of the National Academy of Sciences.
[37] P. Kloetzel,et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells , 2010, The Journal of experimental medicine.
[38] Richard Simpson,et al. Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis. , 2010, Molecular immunology.
[39] K. Murphy,et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells , 2010, The Journal of experimental medicine.
[40] A. Ruddell,et al. Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation , 2010, The Journal of experimental medicine.
[41] S. Turley,et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions , 2010, The Journal of experimental medicine.
[42] Anna M. Keller,et al. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A , 2010, European journal of immunology.
[43] W. Heath,et al. The CD8+ dendritic cell subset , 2010, Immunological reviews.
[44] M. Mann,et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. , 2010, Immunity.
[45] Ren-Huan Xu,et al. Direct Presentation Is Sufficient for an Efficient Anti-Viral CD8+ T Cell Response , 2010, PLoS pathogens.
[46] E. Devilard,et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells , 2010, The Journal of experimental medicine.
[47] T. Randall,et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenza , 2010, Nature Immunology.
[48] F. Ginhoux,et al. The origin and development of nonlymphoid tissue CD103+ DCs , 2009, The Journal of experimental medicine.
[49] Adrian J F Luty,et al. Protection against a malaria challenge by sporozoite inoculation. , 2009, The New England journal of medicine.
[50] I. Wicks,et al. Different cross-presentation pathways in steady-state and inflammatory dendritic cells , 2009, Proceedings of the National Academy of Sciences.
[51] Andreas Hutloff,et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. , 2009, Immunity.
[52] E. Unanue,et al. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation , 2009, Proceedings of the National Academy of Sciences.
[53] Yuzhang Wu,et al. The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells , 2009, Proceedings of the National Academy of Sciences.
[54] M. Lutz,et al. Induction of peripheral CD4+ T‐cell tolerance and CD8+ T‐cell cross‐tolerance by dendritic cells , 2009, European journal of immunology.
[55] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[56] P. van Endert,et al. IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation , 2009, Science.
[57] B. Kyewski,et al. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer , 2009, The Journal of experimental medicine.
[58] D. Roos,et al. Dynamic Imaging of CD8+ T Cells and Dendritic Cells during Infection with Toxoplasma gondii , 2009, PLoS pathogens.
[59] J. Kimpen,et al. Respiratory Syncytial Virus-Induced Activation and Migration of Respiratory Dendritic Cells and Subsequent Antigen Presentation in the Lung-Draining Lymph Node , 2009, Journal of Virology.
[60] D. Filippov,et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity , 2009, Proceedings of the National Academy of Sciences.
[61] N. Hacohen,et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. , 2009, Immunity.
[62] K. Hogquist,et al. Langerhans Cells Are Not Required for the CD8 T Cell Response to Epidermal Self-Antigens 1 , 2009, The Journal of Immunology.
[63] J. Mintern,et al. Characterization of an Immediate Splenic Precursor of CD8+ Dendritic Cells Capable of Inducing Antiviral T Cell Responses1 , 2009, The Journal of Immunology.
[64] Scott A. Brown,et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection , 2009, Proceedings of the National Academy of Sciences.
[65] Anna M. Keller,et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity , 2009, Nature.
[66] N. Van Rooijen,et al. Differential Migration of Epidermal and Dermal Dendritic Cells during Skin Infection1 , 2009, The Journal of Immunology.
[67] A. Iwasaki,et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection , 2009, The Journal of experimental medicine.
[68] F. Ginhoux,et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation , 2009, The Journal of experimental medicine.
[69] F. Faure,et al. Long‐lasting cross‐presentation of tumor antigen in human DC , 2009, European journal of immunology.
[70] S. Rosenzweig,et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. , 2008, Blood.
[71] E. Unanue,et al. Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.
[72] N. Escriou,et al. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. , 2008, Blood.
[73] M. Wright,et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. , 2008, Blood.
[74] T. Brocker,et al. Lentiviral-Mediated Transcriptional Targeting of Dendritic Cells for Induction of T Cell Tolerance In Vivo1 , 2008, The Journal of Immunology.
[75] G. Belz,et al. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8α+ dendritic cells , 2008, Proceedings of the National Academy of Sciences.
[76] J. Villadangos,et al. Antigen-presentation properties of plasmacytoid dendritic cells. , 2008, Immunity.
[77] H. Ueno,et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. , 2008, Immunity.
[78] F. Powrie,et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans , 2008, The Journal of experimental medicine.
[79] M. Castrucci,et al. Primary CD8+ T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo , 2008, Clinical and Vaccine Immunology.
[80] Howard Y. Chang,et al. Deletional Tolerance Mediated by Extrathymic Aire-Expressing Cells , 2008, Science.
[81] M. Glennie,et al. CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses , 2008, European journal of immunology.
[82] Clare L. Bennett,et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells , 2008, The Journal of experimental medicine.
[83] Gordon D. Brown,et al. CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes , 2008, Journal of Biological Chemistry.
[84] D. Pennington,et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. , 2008, The Journal of clinical investigation.
[85] J. Connolly,et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I , 2008, Nature Immunology.
[86] M. Bachmann,et al. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. , 2008, Immunity.
[87] S. Jameson,et al. Langerin Expressing Cells Promote Skin Immune Responses under Defined Conditions1 , 2008, The Journal of Immunology.
[88] R. Tampé,et al. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation , 2008, Nature Immunology.
[89] R. Steinman,et al. Cutting Edge: Langerin/CD207 Receptor on Dendritic Cells Mediates Efficient Antigen Presentation on MHC I and II Products In Vivo1 , 2008, The Journal of Immunology.
[90] Li Wu,et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset , 2008, Proceedings of the National Academy of Sciences.
[91] J. Yewdell,et al. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes , 2008, Nature Immunology.
[92] Sven Burgdorf,et al. The Kidney-Renal Lymph Node-System Contributes to Cross-Tolerance against Innocuous Circulating Antigen1 , 2008, The Journal of Immunology.
[93] N. Van Rooijen,et al. Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues , 2008, Science.
[94] F. Ginhoux,et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.
[95] E. Devilard,et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.
[96] K. Hogquist,et al. Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.
[97] Peter Cresswell,et al. Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells , 2007, The EMBO journal.
[98] C. Benoist,et al. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire , 2007, The Journal of experimental medicine.
[99] Carl G. Figdor,et al. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.
[100] H. de la Salle,et al. Antigen crosspresentation by human plasmacytoid dendritic cells. , 2007, Immunity.
[101] Steffen Jung,et al. Organ-dependent in vivo priming of naive CD4+,but not CD8+,T cells by plasmacytoid dendritic cells , 2007, The Journal of experimental medicine.
[102] Clare L. Bennett,et al. Deletional Self-Tolerance to a Melanocyte/Melanoma Antigen Derived from Tyrosinase Is Mediated by a Radio-Resistant Cell in Peripheral and Mesenteric Lymph Nodes1 , 2007, The Journal of Immunology.
[103] E. Kremmer,et al. CD103− and CD103+ Bronchial Lymph Node Dendritic Cells Are Specialized in Presenting and Cross-Presenting Innocuous Antigen to CD4+ and CD8+ T Cells1 , 2007, The Journal of Immunology.
[104] B. León,et al. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. , 2007, Immunity.
[105] Sven Burgdorf,et al. Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation , 2007, Science.
[106] E. Baple,et al. Virus recognition by specific natural antibodies and complement results in MHC I cross‐presentation , 2007, European journal of immunology.
[107] G. Raposo,et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes , 2007, Nature Cell Biology.
[108] P. van Endert,et al. The Role of Endoplasmic Reticulum-Associated Aminopeptidase 1 in Immunity to Infection and in Cross-Presentation1 , 2007, The Journal of Immunology.
[109] S. Turley,et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self , 2007, Nature Immunology.
[110] R. Steinman,et al. Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.
[111] John D. Venable,et al. Hsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis , 2006, Cell.
[112] P. Cresswell,et al. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. , 2006, Immunity.
[113] Sylvie Bertholet,et al. Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo , 2006, The Journal of Immunology.
[114] R. Bonasio,et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus , 2006, Nature Immunology.
[115] E. Shevach,et al. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.
[116] Shimon Sakaguchi,et al. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.
[117] V. Cerundolo,et al. Role of Immunoproteasomes in Cross-Presentation1 , 2006, The Journal of Immunology.
[118] G. Raposo,et al. NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells , 2006, Cell.
[119] G. Belz,et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[120] J. Villadangos,et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.
[121] V. Lukacs-Kornek,et al. The Mannose Receptor Mediates Uptake of Soluble but Not of Cell-Associated Antigen for Cross-Presentation1 , 2006, The Journal of Immunology.
[122] Steffen Jung,et al. The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity , 2006, European journal of immunology.
[123] J. Sirard,et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. , 2006, Immunity.
[124] G. Belz,et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity , 2006, Nature Immunology.
[125] S. H. van der Burg,et al. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model. , 2005, Vaccine.
[126] C. Borrebaeck,et al. Gene Family Clustering Identifies Functionally Associated Subsets of Human In Vivo Blood and Tonsillar Dendritic Cells1 , 2005, The Journal of Immunology.
[127] S. Grinstein,et al. Quantitative and Dynamic Assessment of the Contribution of the ER to Phagosome Formation , 2005, Cell.
[128] D. Accapezzato,et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo , 2005, The Journal of experimental medicine.
[129] Jae-Hoon Chang,et al. CD8α–11b+ dendritic cells but not CD8α+ dendritic cells mediate cross-tolerance toward intestinal antigens , 2005 .
[130] A. Rudensky,et al. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.
[131] Henry C. Chang,et al. Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.
[132] J. Drijfhout,et al. Cross-presentation by intercellular peptide transfer through gap junctions , 2005, Nature.
[133] S. Gordon,et al. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. , 2004, Blood.
[134] Michael J. Bevan,et al. Central Tolerance to Tissue-specific Antigens Mediated by Direct and Indirect Antigen Presentation , 2004, The Journal of experimental medicine.
[135] K. Rock,et al. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. , 2004, Immunity.
[136] G. Belz,et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[137] P. Heeger,et al. CD8 T Cells Can Reject Major Histocompatibility Complex Class I‐Deficient Skin Allografts , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[138] R. Steinman,et al. In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.
[139] L. Rénia,et al. Protective T Cell Immunity against Malaria Liver Stage after Vaccination with Live Sporozoites under Chloroquine Treatment 1 , 2004, The Journal of Immunology.
[140] Kaan E. Biron,et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain , 2003, Nature Immunology.
[141] R. Tampé,et al. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[142] G. Belz,et al. Epidermal Viral Immunity Induced by CD8α+ Dendritic Cells But Not by Langerhans Cells , 2003, Science.
[143] J. Davoust,et al. ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.
[144] Etienne Gagnon,et al. Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.
[145] A. G. Grandea,et al. Tapasin−/− and TAP1−/− Macrophages Are Deficient in Vacuolar Alternate Class I MHC (MHC-I) Processing due to Decreased MHC-I Stability at Phagolysosomal pH1 , 2003, The Journal of Immunology.
[146] Michel C. Nussenzweig,et al. Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.
[147] Scott N. Mueller,et al. The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens , 2002, The Journal of experimental medicine.
[148] Mark S. Anderson,et al. Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.
[149] M. Bevan,et al. Constitutive versus Activation-dependent Cross-Presentation of Immune Complexes by CD8+ and CD8− Dendritic Cells In Vivo , 2002, The Journal of experimental medicine.
[150] Jan Cerny,et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport , 2002, Nature.
[151] A. Molano,et al. T Cell Recognition of an Engineered MHC Class I Molecule: Implications for Peptide-Independent Alloreactivity1 , 2002, The Journal of Immunology.
[152] O. Lantz,et al. Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathway , 2002, Nature Immunology.
[153] Steffen Jung,et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.
[154] Etienne Gagnon,et al. Endoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages , 2002, Cell.
[155] S. H. van der Burg,et al. Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides1 , 2002, The Journal of Immunology.
[156] R. Steinman,et al. The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo , 2002, The Journal of experimental medicine.
[157] Vasso Apostolopoulos,et al. Structural Comparison of Allogeneic and Syngeneic T Cell Receptor–Peptide-Major Histocompatibility Complex Complexes , 2002, The Journal of experimental medicine.
[158] Yong‐jun Liu,et al. Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.
[159] A. Krasinskas,et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition , 2002, Nature Medicine.
[160] P. Srivastava. Roles of heat-shock proteins in innate and adaptive immunity , 2002, Nature Reviews Immunology.
[161] A. Lupas,et al. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis , 2001, The EMBO journal.
[162] L. Klein,et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self , 2001, Nature Immunology.
[163] Michel C. Nussenzweig,et al. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.
[164] Javier Hernández,et al. Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen , 2001, The Journal of experimental medicine.
[165] L. Klein,et al. Sampling of complementing self‐antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance , 2001, European journal of immunology.
[166] A. Samri,et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. , 2001, Blood.
[167] W. Heath,et al. Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8− Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells1 , 2001, The Journal of Immunology.
[168] A. Valujskikh,et al. INDIRECTLY PRIMED CD8+ T CELLS ARE A PROMINENT COMPONENT OF THE ALLOGENEIC T-CELL REPERTOIRE AFTER SKIN GRAFT REJECTION IN MICE1 , 2001, Transplantation.
[169] M. Bevan,et al. Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.
[170] S. Miltenyi,et al. BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.
[171] Bernard Malissen,et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule , 2000, Nature Immunology.
[172] H. Rammensee,et al. The Role of Peptides in T Cell Alloreactivity Is Determined by Self–Major Histocompatibility Complex Molecules , 2000, The Journal of experimental medicine.
[173] Sebastian Amigorena,et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells , 1999, Nature Cell Biology.
[174] C. Kurts,et al. CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity , 1997, The Journal of experimental medicine.
[175] J. Yewdell,et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.
[176] D. Ladant,et al. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[177] M. Jackson,et al. Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL) , 1997, The Journal of experimental medicine.
[178] A. Prescott,et al. Constitutive macropinocytosis allows TAP‐dependent major histocompatibility compex class I presentation of exogenous soluble antigen by bone marrow‐derived dendritic cells , 1997, European journal of immunology.
[179] J. Miller,et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo , 1996, The Journal of experimental medicine.
[180] D. Ladant,et al. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. , 1996, Journal of immunology.
[181] P. Butko,et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[182] J. Yewdell,et al. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. , 1995, Immunity.
[183] M. Kovacsovics-Bankowski,et al. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.
[184] S. Tonegawa,et al. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.
[185] J. Salamero,et al. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG , 1992, Nature.
[186] Li Wu,et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells , 1992, The Journal of experimental medicine.
[187] C. Janeway,et al. The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia , 1984, The Journal of experimental medicine.
[188] R. Lechler,et al. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells , 1982, The Journal of experimental medicine.
[189] K. Welsh,et al. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients , 1979, The Journal of experimental medicine.
[190] M. Bevan,et al. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? , 1977, Cellular immunology.
[191] M. Bevan,et al. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. , 1976, Journal of immunology.
[192] M. Bevan. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.
[193] S. Turley,et al. Lymph node stroma broaden the peripheral tolerance paradigm. , 2011, Trends in immunology.
[194] Hisao Tajiri,et al. Cancer immunotherapy by fusions of dendritic cells and tumor cells. , 2009, Immunotherapy.
[195] F. Powrie,et al. Small intestinal CD 103 + dendritic cells display unique functional properties that are conserved between mice and humans , 2008 .
[196] N. Bhardwaj,et al. Cross-presentation of cell-associated antigens by dendritic cells. , 2003, Current topics in microbiology and immunology.
[197] G. Belz,et al. Cross-presentation of antigens by dendritic cells. , 2002, Critical reviews in immunology.
[198] C. Janeway,et al. On the intrathymic intercellular transfer of self-determinants. , 1999, Immunology today.